Experimental Alzheimer’s Drug Tests Well

A new drug for Alzheimer’s disease called Rember is being praised by the National Institute on Aging. This drug is only in the earliest stages of testing, but is showing amazing results. The National Institute on Aging — one of the National Institutes of Health here in the United States — helped fund early research that led to the development of drugs like Rember. These drugs are designed to target tau proteins in the tangles that form in the brain of a person with Alzheimer’s disease. For decades, medical research on Alzheimer’s disease has focused on a different kind of … Continue reading

Pre-Dementia is on the Rise

A study from the Mayo Clinic looked at a mild type of memory loss that may precede Alzheimer’s disease. The researchers looked at approximately sixteen hundred adults between the ages of seventy and eighty-nine living near the Mayo Clinic in Rochester, Minnesota. All of the study participants had normal mental and memory function when they joined the study; within a year, more than five percent had developed some impairment. Men in the study were twice as likely as women to develop memory impairment. However, women often live longer and therefore have more time to develop memory issues. Researchers called this … Continue reading